Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Medical Marijuana, Inc. (OTC: MJNA).

Full DD Report for MJNA

You must become a subscriber to view this report.


Recent News from (OTC: MJNA)

Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Host Q&A at Carlsbad Pet & Feed's 2nd Anniversary Celebration
SAN DIEGO , Sept. 6, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Phyto Animal Health will be hosting a Q&A at the Carlsbad Pet & Feed 2nd ...
Source: PR Newswire
Date: September, 06 2018 09:00
Pot stocks perk up premarket
Cannabis stocks are showing some life premarket. Cronos Group (NASDAQ: CRON ) is up  24%  on robust volume, Canopy Growth (NYSE: CGC ) is up  7%  on increased volume and Tilray (NASDAQ: TLRY ) is up  11%  on average volume. More news on: Cronos Group, Inc., Ca...
Source: SeekingAlpha
Date: September, 05 2018 07:50
Citron bearish on Tilray due to valuation; shares up 9%
Citron Research, a buyer of pot stock Tilray ( TLRY +9.4% ) up to $45, is now bearish with a fair value target of $26, calling it "by far the most expensive in the space." The stock is currently exchanging hands at $72 up over four-fold from its IPO price of $17. More news on: Tilray, In...
Source: SeekingAlpha
Date: September, 04 2018 12:19
Venture Breakfast Bits, by 24/7 Market News
Venture Market News for September 1, 2018 eWellness Expands Sales Funnel To Include Major U.S. Oil & Gas Companies Culver City, CA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB:EWLL) – a provider of the state of the art PHZIO platform f...
Source: 24/7 Market News
Date: September, 04 2018 09:58
Medical Marijuana, Inc. and Subsidiary Kannaway® Announce August 2018 as the Largest Sales Month in Company History
SAN DIEGO , Sept. 4, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company and its subsidiary Kannaway® have booked the largest-ever (unaudited) sales month...
Source: PR Newswire
Date: September, 04 2018 09:00
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of its First-Ever CBD Gel Capsules
SAN DIEGO , Aug. 30, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , announced today that its subsidiary Dixie Botanicals® has released new cannabidiol (CBD) gel capsules, the first of their kind fo...
Source: PR Newswire
Date: August, 30 2018 09:00
Profit-taking pressures Tilray, down 4% premarket
Tilray (NASDAQ: TLRY ) slips  4%  premarket on light volume as investors take money off the table after the stock's ~ 160%  run-up since touching $24 on August 14. More news on: Tilray, Inc., Canopy Growth Corporation, Cronos Group, Inc., Healthcare stocks news, Consumer sto...
Source: SeekingAlpha
Date: August, 30 2018 08:09
Trump's secret war on weed - BuzzFeed
The administration's Marijuana Policy Coordination Committee is aiming to combat public support for marijuana and throw a negative spin on state legalization initiatives, writes Dominic Holden. More news on: Tilray, Inc., Canopy Growth Corporation, Cronos Group, Inc., Healthcare stock...
Source: SeekingAlpha
Date: August, 29 2018 13:51
Beverage giants eye Canadian cannabis players
The large investment by Constellation Brands ( STZ +1.1% ) in Canopy Growth Corp. ( CGC +3.8% ) is still reverberating around the beverage industry as some of the larger names scramble to keep up. More news on: Constellation Brands, Inc., Canopy Growth Corporation, Anheuser-Busch InB...
Source: SeekingAlpha
Date: August, 29 2018 10:42
Hemp & Cannabidiol (CBD) Benefits Pushing Consumer Demand to New Highs in Projected Billion Dollar Industry
Palm Beach, FL – (August 29, 2018) – Cannabidiol (CBD) and Hemp oil have come to fuel a multi-billion dollar movement as consumers come to understand the benefits the extracts can provide. The uses for these extracts are endless and their utility is a large reason why the overall H...
Source: MarketNewsUpdates.com
Date: August, 29 2018 08:16

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-180.0940.09850.10090.0912,789,637
2018-12-170.100.09240.10380.0929,982,308
2018-12-140.090050.0970.0970.08223,517,398
2018-12-130.09080.08550.09490.085132,438,741
2018-12-120.0710.08850.0890.0730,863,111

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-185,031,31812,789,63739.3390Short
2018-12-1712,872,04329,982,30842.9321Short
2018-12-1411,898,83222,882,30152.0002Short
2018-12-1313,294,40532,427,74140.9970Short
2018-12-1213,380,37629,338,11145.6075Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MJNA.


About Medical Marijuana, Inc. (OTC: MJNA)

Logo for Medical Marijuana, Inc. (OTC: MJNA)

Medical Marijuana Inc. OTC Pink Sheets MJNA is the first publicly held company vested in the cannabis and industrial hemp space in America. Through its subsidiaries and investment holdings the Company focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol CBD and other products containing CBD rich hemp oil Legal Hemp . Company products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription based hemp oil for sale in countries that have legalized our hemp oil for the treatment of various illnesses and conditions such as Brazil and Mexico and skin care products. The Company is not in the business of selling or dispensing either recreational or medical marijuana, directly or indirectly, so long as marijuana remains a federally controlled substance, however, we are poised and consider ourselves well positioned for eventual cannabis legalization the Company s products contain only those substances that are derived from the part of the cannabis plant that is excluded from the definition of marijuana under the Controlled Substances Act and are both federally legal and outside of the purview of the Drug Enforcement Administration .

 

 

 

Current Management

  • Stuart W. Titus / CEO
    • Assumed role as CEO March
  • Blake N. Schroeder / COO
  • Michael L. Corrigan / Secretary
  • Phillip E Koehnke ESQ / Outside Counsel
  • Robert Cunningham /
  • Chris Prine /
  • Timothy Scott /
  • Michelle Sides /

Current Share Structure

  • Market Cap: $330,351,062 - 03/09/2018
  • Authorized: 5,000,000,000 - 09/30/2016
  • Issue and Outstanding: 3,182,572,856 - 06/30/2017
  • Float: 411,045,323 - 03/31/2013

 



Daily Technical Chart for (OTC: MJNA)

Daily Technical Chart for (OTC: MJNA)


Stay tuned for daily updates and more on (OTC: MJNA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MJNA)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MJNA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MJNA and does not buy, sell, or trade any shares of MJNA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/